Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nerviano Medical Sciences presents new JAK2 inhibitors

Nov. 19, 2012

Zaltrap receives positive CHMP opinion for metastatic colorectal cancer

Nov. 19, 2012

Novel JAK3 inhibitors presented by Cellzome (GlaxoSmithKline)

Nov. 19, 2012

Brazilian researchers disclose new radioactive iodine compounds

Nov. 19, 2012

TAS-117 demonstrates potent antitumor activity alone and in combination

Nov. 19, 2012

Gynecologic Oncology Group begins phase II trial of dalantercept

Nov. 19, 2012

New protein kinase inhibitors disclosed by China State Institute of Pharmaceutical Industry

Nov. 19, 2012

RP-7047 evaluated for the treatment of acute lymphoblastic lymphoma

Nov. 19, 2012

Epizyme and Eisai patent novel agents for cancer

Nov. 16, 2012

U.S. Department of Health & Human Services reports novel PLK1 inhibitor compounds

Nov. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...